GILD

Gilead Sciences, Inc. · Healthcare · Drug Manufacturers - General
$143.44
+4.52 (+3.25%)
Mkt Cap: 178.09B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield6.2%
Dividend YieldN/A
Market Cap178.09B
Volume5.55M
Recent News
Is Gilead's Expanding HIV Portfolio a Growth Catalyst?
zacks.com · 2026-08-18
Gilead Sciences Has Quietly Become One of the Most Underrated Turnaround Stories in Healthcare. Here's Why Wall Street Is Excited.
fool.com · 2026-08-18
Capital Financial Group Inc. Co. ADV Invests $582,000 in Gilead Sciences, Inc. $GILD
defenseworld.net · 2026-08-18
AMG National Trust Bank Purchases Shares of 26,675 Gilead Sciences, Inc. $GILD
defenseworld.net · 2026-08-17
Assembly Biosciences: Gilead Advancements For GS-1179 And ABI-6250 Is A Bullish Signal
seekingalpha.com · 2026-08-16
BIP Wealth LLC Purchases New Holdings in Gilead Sciences, Inc. $GILD
defenseworld.net · 2026-08-16

Unlock the Full Deep Scan

9 AI agents analyze GILD across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →